• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

微管相关组蛋白甲基转移酶 SET8 在转录因子 LSF 的协助下,对α-微管蛋白进行甲基化修饰。

The microtubule-associated histone methyltransferase SET8, facilitated by transcription factor LSF, methylates α-tubulin.

机构信息

New England Biolabs, Ipswich, Massachusetts 01938.

MCBB Graduate Program, Graduate School of Arts and Sciences, Boston University, Boston, Massachusetts 02215.

出版信息

J Biol Chem. 2020 Apr 3;295(14):4748-4759. doi: 10.1074/jbc.RA119.010951. Epub 2020 Feb 28.

DOI:10.1074/jbc.RA119.010951
PMID:32111740
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC7135998/
Abstract

Microtubules are cytoskeletal structures critical for mitosis, cell motility, and protein and organelle transport and are a validated target for anticancer drugs. However, how tubulins are regulated and recruited to support these distinct cellular processes is incompletely understood. Posttranslational modifications of tubulins are proposed to regulate microtubule function and dynamics. Although many of these modifications have been investigated, only one prior study reports tubulin methylation and an enzyme responsible for this methylation. Here we used radiolabeling, MS, and immunoblotting approaches to monitor protein methylation and immunoprecipitation, immunofluorescence, and pulldown approaches to measure protein-protein interactions. We demonstrate that -lysine methyltransferase 5A (KMT5A or SET8/PR-Set7), which methylates lysine 20 in histone H4, bound α-tubulin and methylated it at a specific lysine residue, Lys Furthermore, late SV40 factor (LSF)/CP2, a known transcription factor, bound both α-tubulin and SET8 and enhanced SET8-mediated α-tubulin methylation In addition, we found that the ability of LSF to facilitate this methylation is countered by factor quinolinone inhibitor 1 (FQI1), a specific small-molecule inhibitor of LSF. These findings suggest the general model that microtubule-associated proteins, including transcription factors, recruit or stimulate protein-modifying enzymes to target tubulins. Moreover, our results point to dual functions for SET8 and LSF not only in chromatin regulation but also in cytoskeletal modification.

摘要

微管是有丝分裂、细胞运动、蛋白质和细胞器运输所必需的细胞骨架结构,也是抗癌药物的有效靶点。然而,微管蛋白如何被调节和募集来支持这些不同的细胞过程还不完全清楚。微管蛋白的翻译后修饰被认为可以调节微管的功能和动力学。尽管已经研究了许多这些修饰,但只有一项先前的研究报告了微管蛋白甲基化及其负责这种甲基化的酶。在这里,我们使用放射性标记、MS 和免疫印迹方法来监测蛋白质甲基化和免疫沉淀,免疫荧光和下拉方法来测量蛋白质-蛋白质相互作用。我们证明了赖氨酸甲基转移酶 5A(KMT5A 或 SET8/PR-Set7),它可以甲基化组蛋白 H4 的赖氨酸 20,结合α-微管蛋白并将其甲基化在特定的赖氨酸残基上,Lys 此外,晚期 SV40 因子(LSF)/CP2,一种已知的转录因子,结合了α-微管蛋白和 SET8,并增强了 SET8 介导的α-微管蛋白甲基化。此外,我们发现 LSF 促进这种甲基化的能力被喹啉酮抑制剂 1(FQI1)抵消,FQI1 是 LSF 的一种特异性小分子抑制剂。这些发现表明了一个普遍的模型,即微管相关蛋白,包括转录因子,招募或刺激蛋白质修饰酶来靶向微管蛋白。此外,我们的结果表明 SET8 和 LSF 的双重功能不仅在染色质调节中,而且在细胞骨架修饰中。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/94cb/7135998/c40c254d22c8/zbc9992021760004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/94cb/7135998/aa7ed88ae841/zbc9992021760001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/94cb/7135998/cddddca9e4af/zbc9992021760002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/94cb/7135998/8da6e6150592/zbc9992021760003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/94cb/7135998/c40c254d22c8/zbc9992021760004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/94cb/7135998/aa7ed88ae841/zbc9992021760001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/94cb/7135998/cddddca9e4af/zbc9992021760002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/94cb/7135998/8da6e6150592/zbc9992021760003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/94cb/7135998/c40c254d22c8/zbc9992021760004.jpg

相似文献

1
The microtubule-associated histone methyltransferase SET8, facilitated by transcription factor LSF, methylates α-tubulin.微管相关组蛋白甲基转移酶 SET8 在转录因子 LSF 的协助下,对α-微管蛋白进行甲基化修饰。
J Biol Chem. 2020 Apr 3;295(14):4748-4759. doi: 10.1074/jbc.RA119.010951. Epub 2020 Feb 28.
2
Dual Chromatin and Cytoskeletal Remodeling by SETD2.SETD2介导的双重染色质和细胞骨架重塑
Cell. 2016 Aug 11;166(4):950-962. doi: 10.1016/j.cell.2016.07.005.
3
Factor quinolinone inhibitors disrupt spindles and multiple LSF (TFCP2)-protein interactions in mitosis, including with microtubule-associated proteins.喹喔啉酮因子抑制剂在有丝分裂过程中破坏纺锤体和多个 LSF(TFCP2)-蛋白相互作用,包括与微管相关蛋白的相互作用。
PLoS One. 2022 Jun 15;17(6):e0268857. doi: 10.1371/journal.pone.0268857. eCollection 2022.
4
Transcription factor LSF-DNMT1 complex dissociation by FQI1 leads to aberrant DNA methylation and gene expression.FQI1导致转录因子LSF-DNMT1复合物解离,进而导致异常的DNA甲基化和基因表达。
Oncotarget. 2016 Dec 13;7(50):83627-83640. doi: 10.18632/oncotarget.13271.
5
Purification and functional characterization of SET8, a nucleosomal histone H4-lysine 20-specific methyltransferase.核小体组蛋白H4赖氨酸20特异性甲基转移酶SET8的纯化及功能特性分析
Curr Biol. 2002 Jul 9;12(13):1086-99. doi: 10.1016/s0960-9822(02)00924-7.
6
Proteome identification of proteins interacting with histone methyltransferase SET8.与组蛋白甲基转移酶 SET8 相互作用的蛋白质的蛋白质组鉴定。
Acta Biochim Biophys Sin (Shanghai). 2013 Apr;45(4):303-8. doi: 10.1093/abbs/gmt011. Epub 2013 Feb 17.
7
Molecular determinants for α-tubulin methylation by SETD2.SETD2介导α-微管蛋白甲基化的分子决定因素。
J Biol Chem. 2021 Jul;297(1):100898. doi: 10.1016/j.jbc.2021.100898. Epub 2021 Jun 19.
8
CRL4(Cdt2) regulates cell proliferation and histone gene expression by targeting PR-Set7/Set8 for degradation.CRL4(Cdt2) 通过靶向 PR-Set7/Set8 进行降解来调节细胞增殖和组蛋白基因表达。
Mol Cell. 2010 Oct 8;40(1):9-21. doi: 10.1016/j.molcel.2010.09.014.
9
The ubiquitin-specific protease USP17 prevents cellular senescence by stabilizing the methyltransferase SET8 and transcriptionally repressing .泛素特异性蛋白酶 USP17 通过稳定甲基转移酶 SET8 和转录抑制 ,防止细胞衰老。
J Biol Chem. 2019 Nov 1;294(44):16429-16439. doi: 10.1074/jbc.RA119.009006. Epub 2019 Sep 18.
10
Product specificity and mechanism of protein lysine methyltransferases: insights from the histone lysine methyltransferase SET8.蛋白质赖氨酸甲基转移酶的产物特异性和机制:组蛋白赖氨酸甲基转移酶 SET8 的研究进展。
Biochemistry. 2008 Jun 24;47(25):6671-7. doi: 10.1021/bi800244s.

引用本文的文献

1
TTLL12 is required for primary ciliary axoneme formation in polarized epithelial cells.TTLL12 对于极化上皮细胞中的初级纤毛轴丝形成是必需的。
EMBO Rep. 2024 Jan;25(1):198-227. doi: 10.1038/s44319-023-00005-5. Epub 2023 Dec 19.
2
Tubulin Post-Translational Modifications: The Elusive Roles of Acetylation.微管蛋白的翻译后修饰:乙酰化难以捉摸的作用
Biology (Basel). 2023 Apr 6;12(4):561. doi: 10.3390/biology12040561.
3
Poly ADP-ribosylation of SET8 leads to aberrant H4K20 methylation in mammalian nuclear genome.SET8 的聚 ADP-ribosylation 导致哺乳动物核基因组中 H4K20 的异常甲基化。

本文引用的文献

1
Targeting the oncogene LSF with either the small molecule inhibitor FQI1 or siRNA causes mitotic delays with unaligned chromosomes, resulting in cell death or senescence.用小分子抑制剂 FQI1 或 siRNA 靶向致癌基因 LSF 会导致染色体未对齐的有丝分裂延迟,从而导致细胞死亡或衰老。
BMC Cancer. 2020 Jun 15;20(1):552. doi: 10.1186/s12885-020-07039-1.
2
SET8 prevents excessive DNA methylation by methylation-mediated degradation of UHRF1 and DNMT1.SET8 通过甲基化介导的 UHRF1 和 DNMT1 降解来防止过度的 DNA 甲基化。
Nucleic Acids Res. 2019 Sep 26;47(17):9053-9068. doi: 10.1093/nar/gkz626.
3
Monomethyltransferase SET8 facilitates hepatocellular carcinoma growth by enhancing aerobic glycolysis.
Commun Biol. 2022 Nov 25;5(1):1292. doi: 10.1038/s42003-022-04241-8.
4
SETDB1 regulates microtubule dynamics.SETDB1 调控微管动态。
Cell Prolif. 2022 Dec;55(12):e13348. doi: 10.1111/cpr.13348. Epub 2022 Nov 3.
5
Pharmacologic Manipulation of Late SV40 Factor Suppresses Wnt Signaling and Inhibits Growth of Allogeneic and Syngeneic Colon Cancer Xenografts.药物调控晚期 SV40 因子抑制 Wnt 信号通路并抑制同种异体和同源性结肠癌细胞异种移植瘤的生长。
Am J Pathol. 2022 Aug;192(8):1167-1185. doi: 10.1016/j.ajpath.2022.04.006. Epub 2022 Jun 13.
6
Factor quinolinone inhibitors disrupt spindles and multiple LSF (TFCP2)-protein interactions in mitosis, including with microtubule-associated proteins.喹喔啉酮因子抑制剂在有丝分裂过程中破坏纺锤体和多个 LSF(TFCP2)-蛋白相互作用,包括与微管相关蛋白的相互作用。
PLoS One. 2022 Jun 15;17(6):e0268857. doi: 10.1371/journal.pone.0268857. eCollection 2022.
7
Polyglutamylation: biology and analysis.多聚谷氨酰化:生物学与分析。
Amino Acids. 2022 Apr;54(4):529-542. doi: 10.1007/s00726-022-03146-4. Epub 2022 Mar 31.
8
Factor quinolinone inhibitors alter cell morphology and motility by destabilizing interphase microtubules.醌式因子抑制剂通过使间期微管不稳定来改变细胞形态和运动性。
Sci Rep. 2021 Dec 7;11(1):23564. doi: 10.1038/s41598-021-02962-0.
9
Molecular determinants for α-tubulin methylation by SETD2.SETD2介导α-微管蛋白甲基化的分子决定因素。
J Biol Chem. 2021 Jul;297(1):100898. doi: 10.1016/j.jbc.2021.100898. Epub 2021 Jun 19.
10
Neuronal SETD2 activity links microtubule methylation to an anxiety-like phenotype in mice.神经元 SETD2 活性将微管甲基化与小鼠的类似焦虑表型联系起来。
Brain. 2021 Sep 4;144(8):2527-2540. doi: 10.1093/brain/awab200.
甲基转移酶 SET8 通过增强有氧糖酵解促进肝细胞癌生长。
Cell Death Dis. 2019 Apr 5;10(4):312. doi: 10.1038/s41419-019-1541-1.
4
The PRIDE database and related tools and resources in 2019: improving support for quantification data.PRIDE 数据库及相关工具和资源在 2019 年的进展:提高定量数据支持。
Nucleic Acids Res. 2019 Jan 8;47(D1):D442-D450. doi: 10.1093/nar/gky1106.
5
TFCP2/TFCP2L1/UBP1 transcription factors in cancer.TFCP2/TFCP2L1/UBP1 转录因子在癌症中的作用。
Cancer Lett. 2018 Apr 28;420:72-79. doi: 10.1016/j.canlet.2018.01.078. Epub 2018 Feb 7.
6
Causes and Consequences of Microtubule Acetylation.微管乙酰化的原因与后果。
Curr Biol. 2017 Dec 4;27(23):R1287-R1292. doi: 10.1016/j.cub.2017.10.044.
7
TFCP2 Is Required for YAP-Dependent Transcription to Stimulate Liver Malignancy.TFCP2 对于 YAP 依赖性转录激活促进肝脏恶性肿瘤发生是必需的。
Cell Rep. 2017 Oct 31;21(5):1227-1239. doi: 10.1016/j.celrep.2017.10.017.
8
A subcellular map of the human proteome.人类蛋白质组的亚细胞图谱。
Science. 2017 May 26;356(6340). doi: 10.1126/science.aal3321. Epub 2017 May 11.
9
Microtubules acquire resistance from mechanical breakage through intralumenal acetylation.微管通过管腔内乙酰化作用获得抗机械断裂的能力。
Science. 2017 Apr 21;356(6335):328-332. doi: 10.1126/science.aai8764.
10
Diagnostic and prognostic relevance of CP2c and YY1 expression in hepatocellular carcinoma.CP2c和YY1表达在肝细胞癌中的诊断及预后相关性
Oncotarget. 2017 Apr 11;8(15):24389-24400. doi: 10.18632/oncotarget.15462.